Jukka Kemppainen
Publications
- Tekoäly syövän molekyylikuvantamisessa (2023)
- Erikoislääkäri
(D1 Article in a professional journal) - Value of 68Ga-labeled bombesin antagonist (RM2) in the detection of primary prostate cancer comparing with [18F]fluoromethylcholine PET-CT and multiparametric MRI—a phase I/II study (2023)
- European Radiology
(A1 Refereed original research article in a scientific journal) - Cool-Water Immersion Reduces Post-Exercise Quadriceps Femoris Muscle Perfusion more than Cold-Water Immersion (2022)
- Medicine and Science in Sports and Exercise
(A1 Refereed original research article in a scientific journal) - Correlation of Somatostatin Receptor 1–5 Expression, [68Ga]Ga-DOTANOC, [18F]F-FDG PET/CT and Clinical Outcome in a Prospective Cohort of Pancreatic Neuroendocrine Neoplasms (2022)
- Cancers
(A1 Refereed original research article in a scientific journal) - Diagnostic Accuracy of F-18-FDG-PET/CT and F-18-FDG-PET/MRI in Detecting Locoregional Recurrence of HNSCC 12 Weeks after the End of Chemoradiotherapy: Single-Center Experience with PET/MRI (2022)
- Contrast Media and Molecular Imaging
(A1 Refereed original research article in a scientific journal) - Single Center Experience with a 4-Week 177Lu-PSMA-617 Treatment Interval in Patients with Metastatic Castration-Resistant Prostate Cancer (2022)
- Cancers
(A1 Refereed original research article in a scientific journal) - Tietoruutu L62. Radioaktiiviset ligandit (2022) Farmakologia ja toksikologia Teräs Mika, Kemppainen Jukka
(D2 Article in a professional compilation book) - A Prospective Comparison of 18F-prostate-specific Membrane Antigen-1007 Positron Emission Tomography Computed Tomography, Whole-body 1.5 T Magnetic Resonance Imaging with Diffusion-weighted Imaging, and Single-photon Emission Computed Tomography/Computed Tomography with Traditional Imaging in Primary Distant Metastasis Staging of Prostate Cancer (PROSTAGE) (2021)
- European Urology Oncology
(A1 Refereed original research article in a scientific journal) - More Than Meets the Eye: Scientific Rationale behind Molecular Imaging and Therapeutic Targeting of Prostate-Specific Membrane Antigen (PSMA) in Metastatic Prostate Cancer and Beyond (2021)
- Cancers
(A2 Refereed review article in a scientific journal ) - Prospective comparison of 18F-PSMA-1007 PET/CT, whole-body MRI and CT in primary nodal staging of unfavourable intermediate- and high-risk prostate cancer (2021)
- European Journal of Nuclear Medicine and Molecular Imaging
(A1 Refereed original research article in a scientific journal)



